2802: The State of the Hormone & Peptide Industry w/ Vita Bella Founder Phil Vella

14:22Phil Vella:190 bucks. I'm making money. But then you go to other companies, which I know of. They're in Scottsdale. Oof, I want to call them out so bad. So you got other companies that are charging$1 ,100 for Samoa. And then they're giving you, by the way, two milligrams.

14:35Adam Schafer:So their margin is 80 to 1100.

14:37Phil Vella:And by the way, I'm talking about a 15 milligram vial of some more than not to 15. Yeah, I'm selling 15 milligram vials because they're not that expensive. And all those people that want to come in, they're like, oh, but you're still price gouging, making money. How fucking expensive do you think it is to be successful in this industry? I've got medical insurance, malpractice insurance. I've got EMR systems, portals, shit tons of documents. DEA is licensing medical licensing in every single state is horrifically expensive. Each one of my providers, if I want to get them licensed in every single state, all in, thank God we're getting a little DEA help right now because you only need one DEA right now.

15:15Phil Vella:But when you needed all the DEAs, it's$888 per DEA per state for one single doctor or one single nurse practitioner.

15:24Adam Schafer:So hold on. So that's 880 times 50?

15:26Phil Vella:40 grand. Per person? Per person. Right? That's what it used to be. Now it's just 888. But then you look at all the medical licensing, 30 to 40 grand per practitioner if they want to be licensed. That's just licensing.

15:40Adam Schafer:And how many patients would one practitioner be able to work with?

15:44Phil Vella:You figure if they can, you know, maybe a thousand-ish. Okay.

15:49Adam Schafer:So you try to grow your company, you're going to have to add.

15:51Phil Vella:I have a ton. I just hired another 20 due to the fun that I think we'll be talking about very shortly. All right.

15:58Adam Schafer:Let's get the cat out of it. Let's go there for a second. So what's going on?

16:01Sal Di Stefano:I've had so many of these conversations and everybody's been thanking us.

16:07Adam Schafer:So we worked with Transcend for a little while. They were one of the larger providers of peptides and hormones. And I'm not going to go into details, but let's just say they owe us a lot of money. They owe everyone. They screwed. They did some bad stuff. Some really bad stuff. Lots of complaints coming, all that stuff. What happened? What's happening with the industry? And what's this like? That's a big vacuum. They were a big company, big vacuum.

16:31Phil Vella:Transcend, I think, was one of the staples in the industry. They also were the largest overcharging company in the world. I've never seen prices like what they charge. They had salespeople that literally sold. We don't have even one salesperson in my company. It doesn't exist. It's you and the doctor. If you and the doctor don't decide on it, we're not pushing you meds. Period. It's you. So what happened was is a couple things. One, they screwed over their pharmacy. So they lost Revive and some other things, oh, and a millions of dollars. And the second thing is that they lost their, what's called the PC group owner for people who don't understand the doctors, right?

17:04Phil Vella:So Transcend is an MSO, which is a services organization. And then the medical group, the main doctor won a lawsuit against Transcend to where Transcend couldn't contact patients anymore or do anything like that. And by the way, this is all public knowledge. It's all out on the web. You guys can look up the cases. So Transcend essentially can't even fulfill pharmacy. They can't refund. They can't do anything. They can't talk to people right now. So that's why they're ghosting everybody. That's why they're ghosting everybody. Correct. And so it is fucking Christmas every day for people like us in this industry is, is transcend had so many patients, so many patients that didn't even know what they were paying by the way.

17:48Phil Vella:And so I hired a number of the transcend people. We got them down in from, from Michigan down to Arizona and we are on boarding. a number of patients, by the way, my company has grown 300 % in the last few weeks. Whoa. I just, and so we just, no wonder you're smiling. So we, we are in, and the patients are coming in and literally this is, these are, I have so many cool things. I'll give you guys some of this content so you guys can like post, like these are like real text messages. We'll redact the names. And they're like, yeah, so I'm paying$5 ,000 a quarter for my test. Some more in treatment.

18:24Phil Vella:One more time, three months of Tesla Moreland is$5 ,000. Yeah. And he's like, how much is it going to be with you guys? Cause I don't want to, I want to keep the pricing the same. I was like, unfortunately it's 900. We're not going to be able to get to the$5 ,000 mark. Yeah. And so, and by the way, I'm making money at 900, but, but why, why do you need to overcharge? Why do you need to do these things? It was crazy. But the big things with transcend is I think they had the best education group i'm going to give it to them like the customers that come to us and patients they're educated because the sales people well it's because they've been listening to a podcast

19:01Sal Di Stefano:for you guys for forever who's been teaching them all about peptides for a long time so they come in

19:05Phil Vella:educated so literally i just get on the phone and they're like yeah i'll take ppc i'll take tessa moreland i'll take cjc i want to do a tri-blend give me some different that's like and And it's such, and I'm like, the average spend per patient is 220 % up with new patients. And it's been the greatest thing that's ever happened to my company. And one, I couldn't be more thankful to all of you guys. I know they owe you guys money. I'm sure that we can figure out something for me to take over.

19:38Sal Di Stefano:No, we're more, I think we're more. I was waiting for this.

19:41Phil Vella:Live negotiations, by the way.

19:43Sal Di Stefano:Less about the money and the thing that, you know, I've had, I think I'm up to 13 or 14 calls with other companies that have all been in bidding wars. And for me, it's a black eye for us. You know, we built this not with the intent to sell peptides, supplements, or anything else like that. Like, we're in the business of training clients, helping them with nutrition, getting them in good shape, changing their behaviors, healthy foods, that type of stuff. and yes we have a large audience that loves all those things and so it made sense to look for a company to partner with but man we they all those people have been dumped onto our lab i mean i've got a forum that's got 20 000 peptide users in it of our people 20 000 that they just left out hanging that are just that are furious at us you know and they have no idea how much money they owe us and how screwed we got out of the deal and it's like i mean i'd love to to refund all you people Well, I go bankrupt refunding all of you guys on what they owe you.

20:44Sal Di Stefano:And so for me, it's like I'm so hesitant. And I also come from the medical marijuana space. So I did that for three years. And I know how difficult it is. A lot of patients don't know. They don't know the stress that you have to go through when legislation changed or now you can't do this. And it's like that delays sometimes prescriptions or some of that. And then people get – and they don't get mad at you guys. They get mad at us because we're the ones who introduced that. And so it's been a massive headache for us. And I go back and forth on, do I even want to F with it? Because it's like to risk another black eye on our company when that's not what we do.

21:20Sal Di Stefano:Although I recognize that there's a massive amount of people that it changes their lives. And I use hormone replacement therapy and have for 15 plus years and know what it's been for me. And so, yeah, it's like this, it's an unfortunate challenge and position that we've been put in. and I'm not sure how we solve it yet. And so we've been really slow to decide on what we're going to do because there's not a lot of -

21:44Phil Vella:I think you should hurry up. This is not an IQ test. We're the right company. Very simple.

21:50Sal Di Stefano:There's so many bad actors in the space, which that also reminds me of. And can you agree or not agree?

21:56Phil Vella:I think bad actors, that's very kind of you. Bad actors is very kind. I think there's fucking pigs. They are. There's people that are more worried about money. that's the one thing that's cool is I don't give a shit about money I'll wear$20 t-shirts and sweaters all day long I made the money I worked at Cisco I did that I did the the thing and now it's like my legacy to give back I think one of the cool things about Vitabella and I'm gonna screw myself by saying this live on here because I know some jag off Karen's gonna ruin this for me but since we've opened the company since the founding of the company we're a 100 % five-star reviewed company.

22:32Phil Vella:We don't have a single four star review. Not one, period. Fact. And so another thing is everybody is quick to onboard you, right? They want to just get your money. They want to sell you. They want to get you in front of a doctor and spend like five, 10 minutes with you and get you what you want because that's what you want, order. And we force you to spend 45 minutes with a doc. Go through everything, really understand everything about yourself so that when you leave that phone call and you leave that conversation that you're empowered you you you truly understand what you're getting and i think that's where we've lost medicine is one doctors have become so quick to prescribe shit medicine and more importantly how many times we asked that you don't even know why you're taking something yeah so you don't you just take this i take this pill once a day okay and it'll make me feel but no one no mechanism know what it does no explanation no education yeah right they don't have this for the normal when you're sick kind of group, right?

23:30Phil Vella:There's no three guys sitting there. Let me tell you about what, you know, what a Z-Pack does. Like there's no one doing that. So it's, there's bad actors everywhere. I think that there are a lot of good people though too.

23:42Sal Di Stefano:Did Sal tell you this story on how we got to Transcend, how that happened? It didn't. So we originally started with Dr. Rand and his team. Okay. And a lot of respect for them. Regenerative. Yeah, regenerative. And they're a brick and mortar though. They're a small brick and mortar. And that was the experience we had. Like every patient saw a doctor and got a meeting. The problem was that because they were a small brick and mortar operation, they couldn't handle our volume. So again, I was getting all these complaints of, I can't get an appointment for 30 days. But the service was amazing. Anyone who did get in was just like, oh my God, their team was so great.

24:18Sal Di Stefano:They walked me through everything. They weren't getting oversold. It was just amazing. And so the original problem we were trying to solve was not about the service side. It was now like, who can handle our volume? And so I began hunting for, okay, who can handle our size? And at that time, I didn't know anybody else besides Transcend that could handle our sales volume. And so I was like, okay, let's do it. And it started off pretty good. We had a forum. We were making their doctor come in every single week and educate our audience that we were building and growing. And so the first year or so, when they were making hay and everything was great, it was not so bad.

24:53Sal Di Stefano:But then it quickly went downhill. It quickly turned into, it looked like a greedy thing of just selling them, no follow-up, no teaching them how to use it. It was just a mill that they were turning. And so we got in this predicament of like, we've had what amazing service is like. And I know how important that is. But then we're also at this size where it's like we can't just go with a ma and pa who's going to handhold every single person. Or they need to be at a size where they can talk to that many patients.

25:23Phil Vella:I think there's a blend where you can do both. Right. And I don't even think, I don't think you need to have VIP programs or any of that shit. I think you want that, go to Peter Atiyah. Go to one of those guys. Right. Pay your hundred grand. You want that type of service? Pay for it. But if you're looking for really good service, really good prices, there's good companies out there that do it. I just think that they don't spend enough time actually caring about CS. We're coming from Cisco. We were paid on CSI, Customer Success Index. and so we need to make sure that people are happy and and you guys by the way on any company you guys go to that's how that's the true indication of success is are people happy yeah and because they're not going to leave you by the way no one leaves you really for price and if they do let them go yeah right they leave you for two things results are they getting the results that they want and when they call or email do you pick up the phone that's it it's not hard to be successful it's results and service are they getting their meds in a reasonable amount of time we ship when the minute you get off the phone our average ship time is 48 to 72 hours the front door wow all 50 states 40 40 states i can't do business in california yeah i can't i can't really i can't to it it's the worst it is the most talk about laws i'm out i quit yeah it's in my bylaws someone's gonna have to redo my entire operating agreement does that mean you don't service in california or they have to do not service the state of california okay yeah i may turn it on i've been very big ego of anti i have such bad experience with this state and it's just a legal system yeah right you know you show up and i always say every day it's not an iq test it's an iq test in

27:07Sal Di Stefano:California it is well it's a smart it's a smart strategy uh on your part going back to if your metric is customer service and you know all the loopholes you have to go through in California and what a bitch it is you're gonna and someone else might be going that's crazy that's so much volume you're losing but it's like yeah but I'm gonna have so many headaches and so many disgruntled patients that have no idea that it's not my fault it's all this bullshit loopholes that i have to do and so i probably yeah we had to get because we live in california obviously they would

27:38Adam Schafer:ship our stuff to a mailbox in florida that would then we would forward all the way over here yeah and and one illegal as shit but anyways um it's not that i i don't want to do business i don't want

27:56Phil Vella:to do that i don't want to suffer i don't want patients to suffer why do you need to go and then you have to set up that mailbox you have to do all those additional loopholes why there's so much damn business in this country let someone else deal with that headache and they can specialize in headaches and the people who specialize in headaches make good money so what are the other

28:15Sal Di Stefano:ones so you got 40 so there's what are the other states besides california that are Hawaii Alaska

28:20Phil Vella:New Jersey Kansas any you know they have cpoms where you need to have separate you know California requires a whole separate operating agreement a whole separate company same thing with New Jersey whole separate company. Same thing with Kansas. So you'd have to start a whole other company over here. It needs to be an entirely separate company. There's three states that require that. And then a couple of states that I'm just like, the volume is not there. Okay. And this is probably the only one that you would consider

28:43Sal Di Stefano:maybe building an operation

28:45Phil Vella:over here. It's the fourth largest economy in the world. It's stupid of me to stay away from it. However, from an anxiety, sleeping really good at night and feeling amazing. Like when I wake up in the morning, we school in California. Amazing. I feel good about it

29:01Adam Schafer:we run a business here we know exactly

29:03Phil Vella:what we're talking about so then the laws I mean it's been rough it's crazy so I love by the way I did business here for the better half of my life and I if I turned on California me being Cisco royalty from back I would have a triple probably 10x the company

29:24Justin Andrews:but

29:25Phil Vella:I'm not ready I'm not ready to deal with laws yet I'm not ready to deal with California yet. I will literally open up a separate team to own and operate it because I'm going to need a separate pharmacy. So you can ship to California. You just need a separate pharmacy. That's in California. Got it. There's a lot of little things that you need to do and we've got it. I've got great guy. I was just on a podcast, Rick Nemi, shot off for God's economy. And he, he was, he's got a pharmacy here and he's like, what do you want me to do? And I'm like, I'm not ready. but when i'm ready i will absolutely i'll absolutely turn it on and so i think and it's in discussion every day because it is it's a big economy for us but uh

30:05Sal Di Stefano:maybe in q3 or q4 so explain explain to me because i vaguely know the model yeah um and i love that you're like a disruptor in the space because i think we think of ourselves as disruptors uh how does the how do the different tiers of memberships work and what comes with that

30:22Phil Vella:It's a great question. One damn tier of membership. Oh, that's it? One. 129 bucks a month. Wait, wait, wait. Hold on. That can't cover skin. Watch. Just watch. I got you. Okay. Watch this. Here we go. 129 bucks a month. I can't wait for this close. 129 bucks. I'm going to give it to you straight, right? Ladies and gentlemen. So, 129 bucks a month. You only pay for your first doctor's visit, which is$99. 45-minute consult. 15 minutes, they review your labs. 15 minutes, they go over health history and goals. The last 15 minutes, they build a custom protocol.

30:55Sal Di Stefano:Okay.

30:56Phil Vella:If you have labs in the last six months and they've got everything we need, we could use them. Oh, wow. If you don't have labs. $250. Get ready. No. We give you a full$1 ,100 Quest Diagnostics 34 biomarker panel for 89 bucks. Wow. If you want to upgrade to full comprehensive,$189. That's getting you everything from your IGF-1 levels, D, everything. So you get that with us. And then what do you get? $129 a month. You get all of your ongoing quarterly doctor's visits included. You get your choice included in the package for$129 of injectable testosterone recipient up to max dose. Enclomiphene up to max dose or B12 up to max dose.

31:44Phil Vella:Weekly injections shipped automatic to your house. So that comes with it? Comes with it for$129. You get your testosterone included, 129. But here's where the clincher is. So you get the testosterone, you get everything. And by the way, we just did this. We just started and added in the meds recently. Prior to that, no meds included. What do you get? You get your doc visits, and then you get access to our war chest of medication when you're on the phone with the docs at wholesale pricing. And you get to treat everything from weight loss, hormone therapy, peptide therapy, skin care, anti-aging, injury and recovery, hair loss, you name it.

32:18Phil Vella:the plethora gambit of narcissism and self-esteem okay and your meds get shipped to your front door 48 72 hours 24 hours a day six day a week clinical care team at all times we're online sunday is a

32:33Sal Di Stefano:day of god he rested and so do we so okay so okay let me get this clear then so 129 is it takes care of like which is takes care of me that's what i need to take yeah but let's say i decide that i I want to, I need BPC. I need something else. So then is it a la carte? It's all a la carte, non-subscription.

32:51Phil Vella:Okay. You get to pick. We've got a patient portal. You can go on and click refill, click request meds. Very clean, very intuitive. Come from tech. It should be good. But yeah, you just go on and click what you want. We don't do BPC anymore. We moved over to PDA. Yeah. But yeah, I mean, it's very simple. That's just a precursor to that, right? No. PDA is great. This is great for the pod. So PDA, we replaced BPC with pentadeca-arginate. Yeah, pentadeca-arginate.

33:18Adam Schafer:No, it's the same thing. It's just attached to a different - Yeah, it's the same 15-chain amino acid,

33:22Phil Vella:except arginate at the end is at acetate. And all the studies have shown better absorption, better half-life, better everything. And patients have loved it.

33:30Adam Schafer:Yeah, yeah. I've used both. So have I. Yeah, I have that. Wow. So what's cool about that, because one of the things about this space is what's going to happen in the future, even though it's prescription peptides, the FDA and big pharma seem to be, they don't like the compound pharmacies. They don't like the compound pharmacies because they want their brand name. They want to be able to control things. And this all, of course, with the popularity, in my opinion, with the popularity of GLP-1s, this really pissed them off that, you know, you go buy Ozempic, it costs this much, but you can go get some agglutide from a compound pharmacy for much less.

34:07Adam Schafer:But the way you've set up your company, it's very easy for you to sell this at some point because you've got monthly reoccurring revenue. Yeah.

34:15Phil Vella:It's a SaaS based business.

34:16Adam Schafer:That's what I'm saying. Is that so, so you've actually got an exit potentially, whereas a lot of these other companies, I'm like, how are you guys going to move? What are you going to show? I'm a businessman. Okay.

34:25Phil Vella:Absolutely. I'm a businessman at heart. And, and it is absolutely built for you to show your EBITDA and for you to show your growth and for you to have predictable revenue. It also allows me to continue to offer our price points the way that we do is because I can predict revenue, which allows me to predict on the operating expenses and I can grow. So I do not outgrow my membership just in basic OPEX. So I'll never have the problems that these other companies when they, you know, when you get slow seasons, when you go into summer, people aren't ordering enough and you're going into it. Like, cause you get seasons within this industry.

34:58Adam Schafer:Yours is consistent.

34:58Phil Vella:I'm a consistent industry as far as the membership is concerned. And then we offer the meds at crazy prices. I mean, for pharmaceutical FDA licensed and approved medications, there's nothing like the pricing. It doesn't exist.

35:13Adam Schafer:Wow. And what do you think about the, what I said about the future with the, with big pharma trying to, is that a constant battle? Are you able to, are you still able to do compounded GLPs or those, did they take those off?

35:25Phil Vella:Everything that's currently available is still available. Okay. I should say, let me rephrase that. Everything that was available is still currently available.

35:32Adam Schafer:So trisepatide, semaglutide. Oh, I didn't know that. I thought Eli Lilly shut that down.

35:38Phil Vella:So this is great. We guys can put this up here. Put the readout up. Strive sued Eli Lilly. Strive Pharmacy out of Arizona sued Eli Lilly. One. So pardon me. Pause that. Eli Lilly and the pharmaceutical company sued Strive. Strive won. Now Strive is suing Eli Lilly and the other pharmaceutical company. They're going on the offense now. Whoa. Yeah, this is huge news, by the way, for our industry.

36:04Adam Schafer:This is massive. Yeah, yeah.

36:06Phil Vella:So it's big news for our industry. They are actively suing big pharma for trying to mitigate the industry and trying to come down on compounding pharmacies because there is a need. There is a need for certain meds to be compounded. And if you have the right prescription and you have the right use cases.

36:23Sal Di Stefano:In particular, GLP-1s, in my opinion. What we have found with GLP-1s is most of these patients are dosing is way too high. Yeah, you get it. Almost every single person. We did a thing last year where, and it was just for us, for educational purposes, we took on 50 GLP-1 clients that the three of us met with them weekly and coached them through their weight loss journey. Almost every single one of them, their dosing was off. Too high. Too high. I can't eat. Yeah, too high. I can't eat enough.

36:54Phil Vella:And you wonder why they become skinny fat. Right.

36:56Sal Di Stefano:And it's like, these people can't hit protein intake and lift weights like on these, like it's crazy. But they're getting these already preloaded, this is your dose, or a doctor starting them off at this super dose. So yeah, it's interesting that Eli Lilly and them even have a case because there's so many patients that we have seen that absolutely shouldn't even be at that dosage.

37:17Adam Schafer:And by the way, the political climate, because I follow the space. It's like one second it looks good this way, then it looks that way. But the political climate seems favorable for you guys with RFK because he's pro-compound pharmacy.

37:34Phil Vella:I see RFK all the time. You do? I do. He works out of my gym in Arizona.

37:38Adam Schafer:Really? Yeah. So he's pro-compound pharmacy.

37:42Phil Vella:He's pro-compound pharmacy. He's pro-mushroom. He's pro-everything. Let me tell you, I can tell you that I bet you mushrooms get approval before any peptide or anything else. I think that's number one. Sorry RFK. I've seen the studies on

37:59Adam Schafer:that with PTSD and all that stuff.

38:02Phil Vella:I would go back to your GLP-1 statement. I think it should be illegal to prescribe GLP-1s by themselves. I'm going to say what I said for everybody. It should be illegal to prescribe GLP-1s by themselves because one, you're dosing, so you're going to go catabolic. no matter what you do you're going to go catabolic period you guys know that yes you're going to go catabolic you have to put some sort of ghrh and igf something else to pair it you have

38:26Adam Schafer:to so you're putting some kind of an anabolic like peptide in combination you have to if you're a man

38:31Phil Vella:testosterone right and if you're deficient if you're younger and clomiphene if and you have to give them so how many people like all these companies they just prescribe the glp1 there's no nutrition no like eat one gram one gram of protein there's nothing there's no workout regimen there's no what the fuck do you think is going to happen to you when you're not eating food you're not lifting weight and you're not getting your protein now you're and here's what happens is and you guys know this is then they become skinny fat or they lose their muscle so when they get you could never get off your glp yeah because you if you did destroy your fatter than you were than before you started because your your mbr is gone everything's gone phil people

39:13Adam Schafer:people are going on them and getting osteopenia yep because low calories we worked with the group that we worked with phil i'm telling this is 100 uh there was one woman there was more than one but i remember this one woman who lost 80 pounds uh on a glp1 super low calories she had 50 more pounds to go she was eating under a thousand calories a day and couldn't lose any more weight Her metabolism had plateau. Flat light. And she's like, what do I do? Do I up my dose? I'm like, no. We're going to go down to 500 calories?

39:45Sal Di Stefano:Yeah.

39:46Adam Schafer:So we had to reverse diet her, which was very hard on the GLP-1. And we tried to talk to her about working with getting on a compounded one so she could adjust the dosage because she plateaued. You're also seeing that. You're seeing people lose a bunch of weight and then plateau because they lose so much muscle. Metabolism goes in the tank. Losing their hair. Like you got to strength train. You can't eat too little. And I love what you said about combining it. Because you know that, by the way, the pharma industry agrees with you. So everybody listening right now, Phil's not like making some crazy statement.

40:14Right now, the pharma industry is investing massive R &D in myostatin-inhibiting drugs and compounds to prevent the muscle loss.

40:23Phil Vella:They know this. And K677. They know this. Merck right now just has a clinical tube.

40:28Adam Schafer:Yeah. They know this. So what you just said isn't like you didn't just invent. They know they're just not talking about it right now because they don't have their special drug yet ready to sell with the GLP-1. But they know this is a problem. So I agree with you 100%.

40:40Phil Vella:I fucking obsess on this industry every single day. I wake up, my first two, three hours of the day is reading. I just dive in and read and read. And the GLP-1 problem is massive. The biggest thing no one's talking about is they stick to their titration schedule. Everyone sticks to their, I'm going to go here, I'm going to go forward. if you are continuously losing fucking weight why are you going up in your dose yeah if you're meeting your weight loss why are you because your doctor said that's another thing is medicine's 50 art 50 science i just launched an amazing an amazing comparison on this i have identical twins that means the exact same fucking dna okay they live together they both play pickleball They do the exact same thing.

41:28Phil Vella:They're in the exact same consulting line of work. The identical medication dose for both. You would assume same DNA, same lifestyle. It would work completely different. Wow. Results. Wow. So if two identical twins get completely different results, what the fuck is it going to be for you and me? Right. Like, and so medicine's 50 % art, 50 % science. Even something could work amazing for you and different for you, Sal. And the reason why is, is because all of our bodies are different. They react differently. And so it's even when we prescribe and I'm like, it should work. Does it, and they're like, well, can you guarantee it works?

42:02Phil Vella:No, but that's why we stick with you. And that's why any provider, they should meet with you on the quarterly basis. You have to have check-ins so that way you can adjust. Maybe this doesn't work. Maybe you get a better reaction here. Maybe at this dose, it's better for you. I don't know. It's the same thing with testosterone. We have guys that are like at one 60, not, not going well. They go to like one, one 20, 100. Not that I would ever personally go down, but yeah. They get better results. And he's like, now I feel my libido is better. I'm like, your libido. It could be mental.

42:32Adam Schafer:But it works. No, you're 100%. With testosterone even, it's incredible, the difference. I have a buddy, fitness guy, works out, and he wanted to try what was considered somewhat of a microdose of terzapatite. So it wasn't the full dose at all. Wanted to microdose it. Vomited. Vomited for days. That's how sensitive he was. Whereas other people, you would give that to them. reaction yeah that's what you happen to me too yeah on a micro does not sit well no whereas other people will take a full dose and then uh maybe i need more or whatever there's a radical uh difference uh in variance with the glp ones radical radical my wife if i micro dose her we're talking about five units five units on something where the nor the normal full dose yeah one point 150 units that's right and five units for her sometimes we got to go down to two because she'll get a little bit of indigestion and nausea.

43:26Adam Schafer:I can barely see that on the needle. You're right. It's very sensitive, whereas other people take more. So what you're saying is 100 % correct.

43:34Phil Vella:It's a shame, honestly. And the bad actors where you talk about like customer service, I'm more concerned with bad actors that are giving bad guidance.

43:44Sal Di Stefano:Yeah.

43:45Phil Vella:Because that's what, who gives a shit about our industry and making money? I care about hurting people. like that's ideally what these individuals are doing during this cash grab that's currently going on right now you got influencers that could give two fucks about you oh yeah they could give two fucks about you all they want to do is click bait you and let you run is the bill as high as

44:06Adam Schafer:possible with their fucking user well you know what a lot of people are getting their education from on peptides are uh these uh fitness freaks who take crazy amounts of test steroids and it's not the people you want to get advice from up inside they're taking grams of gear and other

44:23Phil Vella:stuff how can you you guys have had so many amazing people on this show so this is going to be fucking horrible for me talking shit about them how can the guys that come on here that are on nine other things be like this is the one this is the one thing that changed my whole like when i took that everything it's not the combination of the other nine things plus this one thing together that had the synergistic effect you're going to narrow it down that that's why i look at like uh johnson and he's like yeah rapamycin you know i took it out dude you're on 200 medications about that guy that says he wants to live to you're on 200 listen i'm good at math i'm good at math pal there's no way in my right mind he's like yeah we narrowed it down to that one pill you narrowed it down yeah out of 200 medications to one pill what do you think about

45:15Adam Schafer:the future of your industry? Is it because of the bad actors? You know what it reminds me of? The supplement industry does this to themselves all the time where you'll get some third-party, whatever, investigative company will go out and take third-party test supplements. They always come back the same. Eight out of 10 of them didn't have what they said or had other stuff in them. And I'm always like, you guys are going to, you're going to make yourself get regulated. It pisses me off. We are regulated, by the way. You are, but - Research aid, but we are. Yes, you are regulated, but with these bad actors, could you see how they could bring about a regulation that makes it like no more compounding, no more?

45:54Adam Schafer:I think there's no way. Why?

45:56Phil Vella:I personally think there's no way our industry gets destroyed. And the reason why is there will be a revolution like we've never seen before. Yeah, there's too many people to help. It's the first time ever that people have control of their health. Think about this. It's the first time ever that people have preventative control of their health to where, you know, PDA, BPC, like actually going in and seeing if it can happen naturally instead of forcing surgery. It's the first time that you can gain muscle and you can, you know, you know, TB4, TB1. There's so many different things that help out with immunity.

46:29Phil Vella:And for you to come in and take that away, I think it won't get more regulated. I think big pharma is going to get more aggressive in creating their own lines.

46:39Adam Schafer:Oh, I see.

46:40Phil Vella:Because you know why? They're missing out on the revenue. Yeah. And they'll find a way to make this. Truly, I think they're going to not only find their own lines, they're going to find a way to make this insurable.

46:49Adam Schafer:By the way, for people listening right now, just because I remember I asked this question. I asked Dr. Seeds this question. I love him. And he really explained it well. The difference between a drug and a peptide is a peptide, your body already produces. Your body knows what to do with it. it recognizes it. A pharmaceutical drug is basically shoehorning a chemical to attach to receptors and your body doesn't recognize it and we hope it does this and not all this other stuff. When you take BPC or TB, your body makes it already. So what you're doing -

47:22Phil Vella:On some of them, but yes. On some of them, yes. So there's 7 ,000 peptides in the human body. 7 ,000. Peptides are nothing more than short chains of amino acids less than 50. More than 50, it's called a protein. Okay. Very simply. the great part about peptides is imagine you look at a U S map, all the highways go somewhere. You want to go to LA, take this highway. You want to go through Arizona, you take the 10, take the 17. Peptides are nothing more than messengers for the body. It tells you it's like, like shooting a text message, click, click here, slow down my digestion, click, click, stay shabby, click, click, send a text message, pituitary gland, release growth hormone.

47:59Phil Vella:They're, they're, they're natural to the body. A lot of them are natural, right? To the body, but peptides, because you're getting synthetic peptides a lot of times, but BPC, no, but BPC is amazing. By the way, shout out to everybody that's taken BPC and taken PDA. There's 7 ,000 peptides. It's the only one you can't replicate. That 15 chain amino, there's so many GHRHs. There's so many different ones. It's the only one. That's why PDA, God forbid, like we get that taken away from us, we're going to be in big trouble. But there's so many amazing peptides that can do amazing things, but they're just messengers and people are afraid.

48:33Phil Vella:Like it's cool to talk about. But peptides are still new. Is it? What's the first peptide? Insulin. Saved what? Millions, if not tens, hundreds of millions of lives? It's a hundred years ago. A hundred years ago. We brought insulin to market. But like peptides are still new. You have to be careful. You know what we need to be careful of is taking chemicals and putting chemicals in our body that we have no absolute no idea what it's going to happen. Like giving yourself something that your body has and more of it.

49:03Adam Schafer:that's that's considered amazing well what worries me because i remember when this happened maybe it's different now maybe maybe what you're saying is i agree with you so it might be different but i remember in remember 2020 remember the craziness that happened there i remember uh during the covid time there was data showing that thymus and alpha uh might actually help with covid and suddenly you couldn't get thymus and alpha they made it you could not sell it so there's always a part of me that's a little bit like oh man you know when there's enough money they'll find a way but you're saying the opposite there's so much money the way it is now they're going to

49:40Phil Vella:try and figure out how to get into the business you're there's an inflection point this is great there's an inflection point this is the kodak blockbuster inflection point is the world's changing yeah the world is changing right now and those who get behind it will flourish now they're going to figure out dosing mechanisms because like ozempic and these these these peptides they're patenting the dosing they're patenting the route of injection they're patenting certain things that make it easier and that they can actually maintain a patent on so that they can make money they're going to innovate at a speed that they never have before in this market they're going to make compounds with phs that actually can bind and bend together so that they can be injected the body the glows and everything else that everybody's using they're going to find a way to do this fast like mk and all these it's amazing that when mk went on the scheduled tour the category two substance list.

50:43Phil Vella:What's MK? MK677 in Buter Merlin.

50:45Adam Schafer:Oh, yeah, yeah, yeah. So that went schedule.

50:48Phil Vella:Yeah. Is that why you can't get that? Just wait. Okay. But yeah, Merck, I believe it's Merck. Don't quote me. All of a sudden came out with a, yeah, no problem. We can move forward to clinical. We can move forward to phase two. A week later, you didn't even mask it. It went on the category two. And then all of a sudden, yeah, don't worry about it. Everything was good. No problem. So in one hand, it's dangerous for you and we don't have enough studies. But in the other hand, there were no problems with the study. Let's proceed to the advanced clinical phase.

51:19Adam Schafer:Think about that. By the way, that was some strong stuff, man. I would take that and I would just get strong on that stuff. How did, who was it that you said sued Eli? Strive Pharmacy. Okay. So how are they able to do that? Is it, because I know like with certain compounds, you can't patent because they're naturally occurring. with the law how is that with how are they doing that is it like a countersuit because they lost

51:42Phil Vella:revenue when lily tried to sue the countersuit that they're doing right now has to do with and and again i'm not pulling up the studies here but there's i believe it has something to do with the oppression that they're pushing down on compounding pharmacies and trying to make it hard to do business right you're hurting my business so they're like that's the point they're just yeah

52:00Sal Di Stefano:yeah like they tried it that lily's tried to sue first lost and then that's them coming back and being like now we're getting you for all the last revenue for tarnishing our name and how did they

52:09Adam Schafer:win the lawsuit in the first place is it that you can't patent peptides because they're naturally

52:13Phil Vella:it's not it's not that they couldn't patent they said that they they couldn't prescribe like trizapatide and some of glute i forget what the med was but they couldn't prescribe one of them and uh and they went to court and they said you can't stop them and i believe you guys got to look at the quote please god put the quote up on this damn video what are you guys doing the judge

52:31Adam Schafer:says thank god for compounding pharmacies oh wow it was it was like it was one of the most amazing

52:36Phil Vella:wow that was the ruling yeah it was one of the most amazing quotes that i've seen out there but yeah it it definitely was something to um well to your point that we've reached this point where

52:47Sal Di Stefano:i i we can't put the toothpaste back in the tube sure because we what for the first time in decades we've actually slowed down the rate of obesity and we're actually reversing oh yeah i mean that's

53:01Adam Schafer:we've been on the rise for well this is the first years 50 plus years this is the first time a medical intervention uh actually for obesity used properly all right especially if you work with a trainer protein right dosing this is the first time medical interventions actually can make a

53:17Phil Vella:big difference without also killing you almost it's borderline guaranteed you can't you can't

53:25Adam Schafer:stop it from working have you guys have you seen that uh snack food companies are reporting losses airlines are going to start cutting prices because the people are not as heavy they're talking about

53:37Sal Di Stefano:well you even see uh you see the big shift i told i've been talking about this on the show yeah because we know how important protein is you're seeing fast food restaurants with whole new high protein menu and they're pushing that because they know that everybody's going to be

53:52Phil Vella:on a glp1 you have hershey's and a couple of these companies that have hired doctors functional medicine doctors to lead them into the into the next phase i know some of them um that have just been hired getting paid half a million million dollars a year to lead them into the next phase I think the scary part, and this is really the scary part for me, is this is going to end up bankrupting the country. And I'm going to walk you through this. Is Ozempic and Trisapathai going to end up bankrupting the United States? That's a crazy statement. How? Is because the biggest issue we have with our funding right now is Social Security.

54:34Phil Vella:People are going to live longer than they ever have in their life. they are is because you're managing their glucose you're managing their sugar insulin resistance people are going to fundamentally live way longer than they ever have heart disease going down diabetes going down everything obesity related and and blood sugar related and what's going to happen when all of a sudden the social security bill click click click click click you're not We're already on the verge, right? We're 40 billion. I mean, it's going to bankrupt the country as we continue down this line. So they're going to figure that out.

55:14Adam Schafer:They're going to have to. You also have entire industries that are losing money because they are there to treat all of the nasty side effects of obesity and poor health, all the medications. And then, again, snack food companies are reporting losses. clothing companies are changing how they purchase and make sizes and so we're already seeing this being reported and we only have i think the last time we looked how many what percentage americans were on at gp like 20 that's going to go up to probably three quarters well where are they right

55:50Justin Andrews:now to the oral options because i know that for sure is going to like that's the last sort of

55:55Sal Di Stefano:barrier i see with you know they've got them yeah we've got oral options i mean there's oral options

56:00Phil Vella:available the downside is our stomachs are so damn acidic like it breaks it down so you got to take i believe it's like a two point dr dan is is our our main guy on this i think it's like a 2.8 percent bioavailability on the pill so you've got to take like 30 times the dose to get the absorption um it works but it's does it work as well when you get report when people report back or they people have reported back i'm not the the keen on this one but uh people have reported back good i just think that the there's nothing like injectable anything yeah like our stomachs are the Nate they're like i use nasal i use you know the trochies listen there's nothing better than injectable the bioavailability is just so high and and so yeah i mean i uh i think that it's gonna it's gonna be a big it's gonna be the game but we don't even talk about the real side effects of these products we talk about side effects all the times the glp ones and like oh the blindness to this what about like evisceration of heart disease diabetes cancers i mean well the other

57:02Adam Schafer:stuff you mentioned is so low even in the data it's so low the risk of these things is surrounding air and i'm not taking it away you're right the biggest risk is uh you if you don't if you just do it and don't monitor protein and strength training you lose a bunch of muscle that's the risk 100 that's the big risk that everybody's gonna run into unless you and most of these

57:21Phil Vella:people that are taking it they don't have any discipline so they need trainers like we tell them all the time we launched an app to like give them training but i'm still like please god get a trainer yeah like do something you need an accountability buddy yeah that's what you need like everybody needs an accountability i need an accountability buddy on the basic daily shit that i do like phil did you get that meeting shit i missed the meeting but you need someone to help you you know along your pathway it's not just having a person there to tell you what to do It's just holding you accountable for doing what you said you were going to do.

57:51Phil Vella:You obviously got fat and weren't in shape and all this other stuff. Now you have a cheat code. It is. Ozempic and Trisepith, these are all cheat. They're a cheat code, guaranteed insurance policy. But if you get a trainer on top of it, the trainer should give a good amount of nutritional data to you, right? We've had a lot of success.

58:09Adam Schafer:We've had some great success so far, Phil, with people who've worked with our coaches, who've been on a GLP-1, who were able to come off the GLP-1 with a scaled-down kind of process, develop new behaviors, new disciplines, new ways to approach when the hunger comes back. Dr. Seeds communicated this really well, too. All the neural pathways that you had developed around certain behaviors, they start to weaken after you're on a GLP-1 for six months or a year because you're not strengthening them. We've had good success when people come off. And then the ones that are like, oh, I think I need to go back on, they go on a little bit and they come back off, which I think is great because I think the concept of having to stay on something forever, I think that turns off a lot of people.

58:50Adam Schafer:But I think if you do it right, this is the best tool I've ever seen as a trainer, ever. I've never seen a tool as effective as the, if I had this 15 years ago when I was training people.

59:00Phil Vella:Trent, Trent, Trent, I'm just kidding.

59:03Adam Schafer:I'm trying to get people to say that. I'm kidding, I'm kidding. That's good. So you guys are the, are you in another company so the only ones kind of doing monthly membership? You know, there's a few that have come out

59:13Phil Vella:over the time period. From an end-to-end holistic, from an end-to-end, like literally from front to back, anything to do with health, anything to do with your body, your look, how you feel, how you show up every day. We're the only one that offers it end-to-end. There's a couple that come out and they offer a number of different products, but the good part is it's great, but then you still have to pay crazy money. So not only are you doing a membership, but now you're still charging stupid money for meds. The reason why we did our membership is just to control OPEX. And I lose money on the business.

59:43Phil Vella:Like people don't get this. They feel like you're printing cash. No, because I don't give a shit. I didn't build this business for money. I built it for a legacy. I built it to change people's lives. That's the difference is you've got people that are trying to make it, make their money, make all this return of investment. I don't give a shit. There's nothing I want to buy. There's nothing I want to invest in. There's no North Star of a dollar figure. I'm like, if I just had this much money, I have enough money for me to be happy. And so now it's my time to give people the opportunity to literally unlock the best version of themselves.

1:00:20And so we are.

1:00:22Phil Vella:The membership pieces were the best of the memberships. There's probably, by now, 10, 15 different companies. Of the bigs, Hone is really the only one that has a membership. And then you've got the ones that are just one product memberships. Just GLP One membership or just testosterone. and what do you got, Peter MD, and we got all these other, who they just suffer on quality of care. Maybe one day we do suffer on quality of care, and guess what? I will slam the pause button on the company, because I can. Nobody can do that. Like, that's the difference. No one's willing, no one can lose money.

1:00:56Phil Vella:No one can lose money, and so.

1:00:58Sal Di Stefano:I shared a clip with these guys the other day. I was actually really surprised to hear this. I think it was on 60 Minutes with Peter Atiyah, and she did like a rapid fire thing with him and she asked him. Most overrated. Yeah, most overrated thing in the fitness space right now and he said peptides. He round about it though.

1:01:16Phil Vella:Did you show him the rest of the clip? No. No. So what else? He talked, he specifically, I saw the same thing, the rest of the clip. I'm going to give a shout out to Peter. He said because it's research, you don't know where they're coming from. He goes, you need to get them from, so there's a manipulated clip. So they cut the clip. You need to get the whole clip. it's a manipulated clip. Yeah. It's a manipulation.

1:01:37Sal Di Stefano:I was so surprised. I share with this guy. Cause I was like, you know, a lot of what Peter Tia says aligns with a lot of things that we talk about. And I was like, wow, I'm really surprised that he said that.

1:01:45Phil Vella:He's a hundred percent in amount of peptides. He's a hundred pieces peptides. And then he goes specifically research peptides. And then he goes through and he goes, you don't know where they're coming from. They're not from a lab. They're not from here. They're not QC. So people manipulated that. I posted it on our own wall and people didn't finish watching. and they're like, well, what the fuck? Why am I taking it? I immediately took it down because I'm like, shit, this is going to cause me a nightmare because people didn't want to watch. They're like peptides. And then they just ended it and immediately sent us a support email.

1:02:14Phil Vella:Oh, wow. And they're like, how dare you do that and put Peter and I'm like, oh God, these people don't want to watch the whole clip. Like there's 60 seconds up, you watched eight. Yeah.

1:02:26Sal Di Stefano:People have been chopping it like that. It's chopped to just him saying that. Manipulation. Well, that makes sense. Now it all makes sense.

1:02:32Phil Vella:He's, by the way, I love the guy. I think he's great. He's a wealth of knowledge. I just hate how he flip-flops, but that's also a good thing. He's one of the only doctors that come out. He'll say, I changed my mind. Strong on one product, and when he gets enough research, he'll change his mind. I appreciate that. And the level of respect that you have to have for somebody like that is hard because he goes hard. When he believes in something, he goes hard.

1:02:54Sal Di Stefano:I feel like we're like that. Lane's like that. Lane's done that. Yeah, yeah, yeah. I think we will be staunch about something until the research comes out and we'll prove it otherwise. But we'll be the first ones to admit it, though, when it does. I mean, we were that way on EAAs. Remember how we were on EAAs? We talked a lot of shit about it for a very long time and then was blown away by some of the research and studies and said, okay, it makes sense for this person in this situation. I get it.

1:03:16Phil Vella:What do you guys think about some of these new drugs that are coming? I say new, newer, right? The Samorlans, that's Samorlans, all that's been around for a while. but Sloop and Mott C and all these other products that people are coming out with, which by the way, I just jumped on them right now. So before I get my feedback.

1:03:31Sal Di Stefano:Sal's taking them all. Sal's taking them all. I take everything. I have my, like the BPC and what's the replacement of that right now? PDA. Yeah, PDA. I think between those and GLP-1, everything else pills in comparison in my opinion. And I've tried a lot of them, but I've been injured a lot of times, played sports and stuff like that and i know what it's like to recover from an injury without bpc and then with it it is it's literally 50 of the recovery time i like half so if you're something that whatever injury you have it should take 16 weeks whatever half the recovery time that's

1:04:08Phil Vella:that's miraculous to me i throw in that so we throw in a i throw in nangelone all the time when we do this nangelone is a fantastic and i would say thymus and beta with that right also

1:04:17Sal Di Stefano:so it's a 500 increase in collagen it's the only one that has that type of

1:04:25Phil Vella:and low doses it's good you still got a problem down yeah we know how good all that stuff works

1:04:29Sal Di Stefano:that's yeah but as far as the og yeah yeah we know how good all that stuff works right to the og network but from the peptide space i've been most impressed with those those are the ones that i think uh and we've we've tried a lot motsi c max tried the and he's messed with everything i think

1:04:45Adam Schafer:I think Sloop's interesting. I've seen the reviews and some people rave about it. I tried Sloop. I tried it. Won't say who recommended it to me or the dose they recommended, but let's just say it's a buddy of mine that gets a little overzealous. He gets hyped. And I was taking such a crazy, I didn't know it was a crazy dose, but he's like, no, no, try this, you'll love it. Couldn't sleep. I felt terrible. It was like too much. So I haven't touched it since. Motsi, amazing. I felt so good. And some people take it and they don't notice anything. It's hit and miss, yeah.

1:05:15Phil Vella:I just had our docs build a protocol at MOTC. And I'm like, all right, guys, build a protocol at MOTC. They come back to me in like three hours, fully done. And I'm like, really? And he goes, Phil, there was more research that we found on MOTC than some of the stuff that we've had around for forever. He goes, because we pulled 15 studies in a matter of 20 minutes. We fully protocoled it out. We got it built. And I'm like, there's no way. And he goes, Phil, this is amazing. It's one of my favorites.

1:05:41Adam Schafer:It's one of my favorites. I took it and I just had this incredible difference in energy and well-being. I know Justin had a good experience from it. It's good energy. You take glutathione? Glutathione I'll use occasionally. You know when I use glutathione? I'll use injectable glutathione if I drink. Then I'll use it. Or if I'm getting sick, then I'll use it. Same. My wife has a really bad reaction from alcohol. If she drinks, sometimes she'll wake up in the middle of the night, sweat, won't feel good. If I give her glutathione, then that doesn't happen to her. So that's the other one.

1:06:11Sal Di Stefano:glutathione nad are solid especially for situations like that so nad

1:06:19Phil Vella:we've got a little under 100 meds and nad represents almost 40 percent of the entire

1:06:26Sal Di Stefano:company's revenue wow really i told how much i told these guys we've done it we've done every we've done everything from the patch the iv all the stuff liposoma whatever um and i went through something I shared on the show a couple months back where I came off of Kratom. I had a Kratom addiction, came off of it, had some of the worst opiate withdrawals I've ever had in my life and went and got a NAD drip and it was like crazy what a difference I felt like. And that was what sold me. I had already messed with it enough times like, oh, I think I feel a little bit better. Take your, crash your body and your health really, really bad and then take it and you can feel a night and day difference.

1:07:05Sal Di Stefano:That was enough for me to be sold on like, okay, this is this is definitely working especially in a situation like that so i'm sold on nad i use glutathione so there's a lot of them out there i think there's a lot though that like i didn't i didn't feel much from tessa morland ibutamorin felt the appetite increase and i felt my sleep

1:07:21Adam Schafer:so i did like that so i felt the i felt buying the bpc and thymus and beta or tb500 and that's like amazing oh yeah that's i mean you get performance enhancement uh effects from that At least I do in the gym. So that's a good combination.

1:07:36Phil Vella:Your recovery. Yes. Wolverine's back. Amazing. I think all the GHRPs have been fantastic. I just think you got to get the right dose, right? Samorilin, Tessamorilin, Ipamorella, and CJC. Ipamorella, and I think probably the best one because you're in the 500 synergistic.

1:07:49Sal Di Stefano:Part of me feels like I'm jaded because I've taken regular human growth. Real growth? Yeah, real growth for a long time. So if you compare to that, I just feel like it's hard.

1:08:00Phil Vella:I mean, you're talking about a scooter and a crotch rocket.

1:08:03Sal Di Stefano:Okay. I mean, these are, that's probably why I'm, I'm, I feel that way about it. Cause I'm just like, yeah, I mean, there's nothing like that.

1:08:11Phil Vella:I think that, but I also think that like, there's little things that you can do like with certain peptides, even with testosterone, basic stuff, like people, they're on Sipunate, Sipunate their whole, their whole life. And I was like, have you tried tri-blend? Have you done like propionate and anthonate and Sipunate together? And they're like, what's that? And you're like, it's really good on the days you inject and like just doing different things. I mean, that's what we've been playing with.

1:08:33Adam Schafer:Oh, so you guys will sell those?

1:08:34Phil Vella:Oh, yeah. We have every one of them. Oh, wow, interesting. And we've got them separated. We've got them connected. We've got them together.

1:08:39Adam Schafer:A lot of people don't know this either. The ester will actually lower the amount of testosterone that's available. So testosterone propionate at 100 milligrams is more than 100 milligrams at enanthate because some of it's locked up.

1:08:50Phil Vella:And what's crazy is you've got these clinics that are doing one injection a week. I think that's criminal. Yeah, that's... And then they're like, yeah, my... Listen, first of all, minimum twice a week. Yeah. Minimum. I don't care when anybody... I've got enough labs because there's a lot of people that are smart. They've got a lot of knowledge, a lot of studying. I've got applied knowledge. It's completely different. I get to see the labs on a daily basis. I get to watch humans. Like a Monday, Thursday is absolutely fantastic, right? Just because you get more of a baseline. And then you do three different esters.

1:09:19Phil Vella:And then so now you get a really cool little map on that. And I'm lucky enough I can take my labs on a daily basis if I wanted to or weekly basis. And so then you've got other cool things that we've also introduced is we now mix the anastrosal in with the testosterone oil because i got tired of the men men are dumb we're just stupid we're ego we're forget you get your testosterone shot you're gone i forgot wow i forgot what happened so you're putting it in the testosterone yeah so we mix it within the oils we put the arimidex

1:09:46Adam Schafer:inside of the oil oh interesting well that's kind of smart that way you don't forget it and so i got

1:09:50Phil Vella:tired of the support emails and calls and like hey you know my nipples hurt or that and i'm like listen did you he's like oh i forgot so now we just removed interesting all of that you put 0.25 or 0.5 in with the oil so that way when they get their shot that's smart it automatically hits the body and then i ran a ton of studies recently on oxangelone because we got everybody just hits us up every day for this yeah um it's anivore yeah anivore and so like the guys like i want 50 milligrams i was like you realize if you took like 10 in the morning 10 at night that would crush 50 in the morning wow and so when you watch it on the graph and you see the levels and you see like the experience like this the little tiny things that we do that is different from some of these other companies same thing with our injury recovery protocols adding nangelone and bpc like these are great products but when you pair them and you stack them together like the synergistic

1:10:39Sal Di Stefano:effects well just to echo what you're saying you know i i've i've been getting my testosterone through a clinic for like i said over a decade now and i've had now three four different doctors that have done it and they all were on the one shot a week thing for me and i also uh i don't know what the term is but like my body like so i would spike really hard by day seven i was like below what i think oh yeah it was 200 or something and so then they moved it to like a little bit higher dose still same problem then they went to day six state still still a problem so it ended up being like every four to five days is what i need to keep that from that huge crash and so

1:11:23Phil Vella:The natural pulsatile release of the body is every three, three and a half days. That's the natural pulsatile release of the body. And so if you can stick close to that, you'll keep a lot better. And then you won't get the big estrogen spikes.

1:11:38Adam Schafer:Some people are going to sub-Q or doing testosterone sub-Q.

1:11:41Phil Vella:I've heard a lot about this. My brain can't get around it. I just can't pull the oil for three and a half hours sitting there like watching this go into the damn needle. I'm just like just sitting there. I feel like a Jeopardy song needs to come on. I'm just sitting there waiting for the oil to come in.

1:11:56Adam Schafer:All right. So, Phil, I want to do, I got, I'm going to ask you nine rapid fire questions. Got it. You're just going to give me the best peptide for each of them. Say it again? Are you going to give me the best peptides or whatever for each of the things that I do?

1:12:07Phil Vella:All right. I'll give you your best.

1:12:09Adam Schafer:It's got to be, it's not a conversation, just boom. All right. You ready? Gut healing.

1:12:13Phil Vella:BPC PDA.

1:12:13Adam Schafer:All right. Joint pain and inflammation.

1:12:20Phil Vella:Probably same, adding glutathione.

1:12:22Adam Schafer:All right. Fat loss.

1:12:25Phil Vella:Trisepatide.

1:12:26Adam Schafer:Muscle recovery.

1:12:30Phil Vella:Muscle strength recovery. Muscle recovery, I'd probably go CJC, impamorelin for best effects.

1:12:35Adam Schafer:Sleep quality.

1:12:36Phil Vella:Sleep dissip.

1:12:38Adam Schafer:Anxiety and stress. A good woman. You guys sell those too? Skin, hair, anti-aging.

1:12:50Phil Vella:Skin, hair, and anti-aging. GHKCU, you guys could do the glow stacks, but GHKCU is great for skin hair.

1:12:58Adam Schafer:All right, libido.

1:13:00Phil Vella:You got PT-141, and we also brought a new drug to market, which we'll talk about. I want to definitely get to that, but blood pump.

1:13:07Adam Schafer:Okay, brain focus and cognition.

1:13:11Phil Vella:Brain focus and cognition. Let's see, what's that going through? I like NADs, and that's obviously coenzyme. Enzyme, brain focus. You guys do CMAX? 5-Amino 1MQ I like. I like CMAX, Cell Anc. I like SS31. I mean, there's a ton of stuff there.

1:13:30Adam Schafer:And then injury repair.

1:13:33Phil Vella:By far, PDA, TB500, and then stack it with some Nandrolone and some testosterone on top of it.

1:13:40Adam Schafer:Oh, that'll do it. Well, bro, this has been a good time. Absolutely. Yeah, thanks for coming on the show. It's a lot of fun. I appreciate someone like you in the space. and we'll see what happens. This has been fun, man. Thank you again. Thank you.

1:13:51Justin Andrews:Thank you for listening to Mind Pump. If your goal is to build and shape your body, dramatically improve your health and energy, and maximize your overall performance, check out our discounted RGB Super Bundle at mindpumpmedia.com. The RGB Super Bundle includes MAPS Anabolic, MAPS Performance, and MAPS Aesthetic, nine months of phased expert exercise programming designed by Sal, Adam, and Justin to systematically transform the way your body looks, feels, and performs. With detailed workout blueprints and over 200 videos, the RGB Super Bundle is like having Sal, Adam, and Justin as your own personal trainers, but at a fraction of the price.

1:14:33Justin Andrews:The RGB Super Bundle has a full 30-day money-back guarantee, and you can get it now plus other valuable free resources at mindpumpmedia.com. If you enjoy this show, please share the love by leaving us a five-star rating and review on iTunes and by introducing Mind Pump to your friends and family. We thank you for your support, and until next time, this is Mind Pump.